10 Lupus Clinical Trials in Tucson, AZ (2026)

Q: How do I join a clinical trial in Tucson?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you.

Recruiting Lupus Studies in Tucson

NCT05934149Recruiting

Lupus Landmark Study: A Prospective Registry and Biorepository

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Eryth...

Tucson, AZ3,500 participantsLupus Research Alliance

View Study Details

NCT07679282Recruiting

A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in Adults

Researchers want to identify which treatments for obstructive sleep apnea (OSA) work best and are easiest for patients to use consistently. Eligible participants will be randomly assigned one of three...

Tucson, AZPHASE42,400 participantsSairam Parthasarathy

View Study Details

NCT07345767Recruiting

Hypknowledge Nationwide Sleep Extension

The main goal of this study is to evaluate whether a manually determined sleep extension intervention is effective at improving sleep and related outcomes among adults who find it difficult to get eno...

Tucson, AZNA1,038 participantsUniversity of Arizona

View Study Details

NCT07484217Recruiting

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal tr...

Tucson, AZPHASE3508 participantsAxsome Therapeutics, Inc.

View Study Details

NCT07430306Recruiting

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

The purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti...

Tucson, AZPHASE3245 participantsAstraZeneca

View Study Details

NCT07280468Recruiting

Endotype DIrected Treatment for OSA in Down Syndrome

Down syndrome is the most common genetic cause of intellectual disability. People with Down syndrome often have obstructive sleep apnea (OSA), a condition where people have difficulties with breathing...

Tucson, AZPHASE4200 participantsUniversity of Arizona

View Study Details

NCT05988385Recruiting

The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen 400 cognitively normal older...

Tucson, AZNA200 participantsCalifornia Pacific Medical Center Research Institute

View Study Details

NCT05588934Recruiting

Caffeine Optimization Versus Standard Caffeine Dosage (2B-2)

This clinical trial will be a comparison between personalized recommended caffeine dosing regimen versus the standard recommended caffeine dosing regimen for sustaining performance during sleep depriv...

Tucson, AZNA180 participantsUniversity of Arizona

View Study Details

NCT07391852Recruiting

Circadian Light Exposure Adjustment for Restfulness

Many young children are exposed to light int he evening hours before bedtime. Children's biological clocks are highly sensitive to evening light exposure, which can delay the timing of the clock and m...

Tucson, AZNA60 participantsUniversity of Arizona

View Study Details

NCT06613360Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Phase 1b, open-label study of CLN-978 administered subcutaneously in patients with Moderate to Severe Systemic Lupus Erythematosus (SLE)....

Tucson, AZPHASE124 participantsCullinan Therapeutics Inc.

View Study Details

About Lupus Clinical Trials in Tucson

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.

There are currently 10 lupus clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 8,355 participants. Research is being sponsored by Lupus Research Alliance, Sairam Parthasarathy, University of Arizona and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Clinical Trials in Tucson — FAQ

Are there lupus clinical trials in Tucson?

Yes, there are 10 lupus clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What lupus treatments are being tested?

The 10 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.

Data updated October 19, 2026 from ClinicalTrials.gov